Citius Pharmaceuticals Statistics
Total Valuation
CTXR has a market cap or net worth of $18.01 million. The enterprise value is $12.12 million.
Important Dates
The next estimated earnings date is Wednesday, May 13, 2026, after market close.
| Earnings Date | May 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
CTXR has 22.38 million shares outstanding. The number of shares has increased by 107.77% in one year.
| Current Share Class | 22.38M |
| Shares Outstanding | 22.38M |
| Shares Change (YoY) | +107.77% |
| Shares Change (QoQ) | +24.97% |
| Owned by Insiders (%) | 2.20% |
| Owned by Institutions (%) | 7.50% |
| Float | 21.88M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 0.41 |
| PS Ratio | 4.57 |
| Forward PS | 0.21 |
| PB Ratio | 0.23 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 3.07 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.99, with a Debt / Equity ratio of 0.02.
| Current Ratio | 0.99 |
| Quick Ratio | 0.31 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -87.24 |
Financial Efficiency
Return on equity (ROE) is -47.85% and return on invested capital (ROIC) is -28.08%.
| Return on Equity (ROE) | -47.85% |
| Return on Assets (ROA) | -17.68% |
| Return on Invested Capital (ROIC) | -28.08% |
| Return on Capital Employed (ROCE) | -36.14% |
| Weighted Average Cost of Capital (WACC) | 12.44% |
| Revenue Per Employee | $171,483 |
| Profits Per Employee | -$1.56M |
| Employee Count | 23 |
| Asset Turnover | 0.03 |
| Inventory Turnover | 0.04 |
Taxes
In the past 12 months, CTXR has paid $1.06 million in taxes.
| Income Tax | 1.06M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -23.33% in the last 52 weeks. The beta is 1.38, so CTXR's price volatility has been higher than the market average.
| Beta (5Y) | 1.38 |
| 52-Week Price Change | -23.33% |
| 50-Day Moving Average | 0.79 |
| 200-Day Moving Average | 1.15 |
| Relative Strength Index (RSI) | 49.81 |
| Average Volume (20 Days) | 517,236 |
Short Selling Information
The latest short interest is 4.04 million, so 18.08% of the outstanding shares have been sold short.
| Short Interest | 4.04M |
| Short Previous Month | 3.34M |
| Short % of Shares Out | 18.08% |
| Short % of Float | 18.48% |
| Short Ratio (days to cover) | 5.47 |
Income Statement
In the last 12 months, CTXR had revenue of $3.94 million and -$35.89 million in losses. Loss per share was -$2.46.
| Revenue | 3.94M |
| Gross Profit | 3.15M |
| Operating Income | -36.93M |
| Pretax Income | -37.80M |
| Net Income | -35.89M |
| EBITDA | -36.36M |
| EBIT | -36.93M |
| Loss Per Share | -$2.46 |
Full Income StatementBalance Sheet
The company has $7.72 million in cash and $1.83 million in debt, with a net cash position of $5.89 million or $0.26 per share.
| Cash & Cash Equivalents | 7.72M |
| Total Debt | 1.83M |
| Net Cash | 5.89M |
| Net Cash Per Share | $0.26 |
| Equity (Book Value) | 93.47M |
| Book Value Per Share | 3.57 |
| Working Capital | -261,987 |
Full Balance SheetCash Flow
| Operating Cash Flow | -34.84M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 574,512 |
| Net Borrowing | 1.00M |
| Free Cash Flow | -34.84M |
| FCF Per Share | -$1.56 |
Full Cash Flow StatementMargins
| Gross Margin | 79.99% |
| Operating Margin | -936.38% |
| Pretax Margin | -958.29% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
CTXR does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -107.77% |
| Shareholder Yield | -107.77% |
| Earnings Yield | -199.23% |
| FCF Yield | -193.39% |
Analyst Forecast
The average price target for CTXR is $6.00, which is 645.34% higher than the current price. The consensus rating is "Buy".
| Price Target | $6.00 |
| Price Target Difference | 645.34% |
| Analyst Consensus | Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on November 26, 2024. It was a reverse split with a ratio of 1:25.
| Last Split Date | Nov 26, 2024 |
| Split Type | Reverse |
| Split Ratio | 1:25 |
Scores
CTXR has an Altman Z-Score of -3.08 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -3.08 |
| Piotroski F-Score | 2 |
